RxNorm Concept ID 1803932

leucovorin 100 MG Injection

Semantic Concepts

RxNorm semantic concepts for the RxCUI 1803932 unique identifier include: leucovorin 100 MG Injection (8242810), leucovorin (as leucovorin calcium) 100 MG Injection (8242811) and leucovorin 100 MG Injection (12334307).

RxNorm Atom ID: 8242810 - Prescribable Name

leucovorin 100 MG Injection

Field NameField ValueField Description
RXCUI1803932RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI8242810Unique identifier for the atom (RxNorm Atom ID)
Concept Descriptionleucovorin 100 MG InjectionDescription of concept identifier
Term Type (TTY)PSNTerm type in source with name and description
Term Type NamePrescribable NameName of term type in source
Term Type DescriptionSynonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.Description of term type in source
CODE1803932"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_220906FThe source version
Source DateSeptember 06, 2022RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 8242811 - Synonym

leucovorin (as leucovorin calcium) 100 MG Injection

Field NameField ValueField Description
RXCUI1803932RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI8242811Unique identifier for the atom (RxNorm Atom ID)
Concept Descriptionleucovorin (as leucovorin calcium) 100 MG InjectionDescription of concept identifier
Term Type (TTY)SYTerm type in source with name and description
Term Type NameSynonymName of term type in source
Term Type DescriptionSynonym of another TTY, given for clarity.Description of term type in source
CODE1803932"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_220906FThe source version
Source DateSeptember 06, 2022RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom ID: 12334307 - Semantic Clinical Drug

leucovorin 100 MG Injection

Field NameField ValueField Description
RXCUI1803932RxNorm Unique Identifier for a concept (Concept ID)
LATENGLanguage of the Term
RXAUI12334307Unique identifier for the atom (RxNorm Atom ID)
Concept Descriptionleucovorin 100 MG InjectionDescription of concept identifier
Term Type (TTY)SCDTerm type in source with name and description
Term Type NameSemantic Clinical DrugName of term type in source
Term Type DescriptionIngredient + Strength + Dose FormDescription of term type in source
CODE1803932"Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress FlagNSuppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF4096Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
SourceRXNORMConcept source abbreviation
Source NameRxNorm VocabularyThe official name for a source
Source Version20AA_220906FThe source version
Source DateSeptember 06, 2022RxNorm data last updated
Source License ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source license contact information
Source Content ContactRxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/
The source content contact information
Source Short NameRxNorm work done by the National Library of MedicineThe short name of a source as used by the NLM Knowledge Source Server

RxNorm Atom 12334307 Attributes

PropertyValueExplanation
RXN AI{1803931} 225852RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM{1803931} 6313RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH100 MGAvailable drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM{1803931} AMSource of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUGUSDrug available for use in Humans

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Information for Patients

Leucovorin

Leucovorin is used to prevent harmful effects of methotrexate (Rheumatrex, Trexall; cancer chemotherapy medication) when methotrexate is used to treat certain types of cancer. Leucovorin is also used to treat people who have accidentally received an overdose of methotrexate or similar medications. Leucovorin is in a class of medications called folic acid analogs. It works by protecting healthy cells from the effects of methotrexate or similar medications while allowing methotrexate to enter and kill cancer cells.
[Read More]

* Please review the disclaimer below.